ArticleSignal transduction and targeted therapy2023

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).

Hai-Dong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.